346 Bivalirudin use during continuous renal replacement therapy in a 2.5-year-old girl suffering from cardiomyopathy and receiving VAD support

Abstract

6.027 (95% CI, 3.996-9.090) for inotropic drug usage, 2.348 (95% CI, 1.547-3.564) for RBC transfusion requirement, 1.655 (95% CI, 1.162-2.356) for RDW>15.1% and 2.950 (95% CI, 1.933-4.503) for PLT < 150 × 103/uL.The AKI is associated with prolonged hospitalization and increased mortality.among critically ill children. In patients with AKI, the need for mechanical ventilation, CRRT and inotropic drugs was statistically associated with mortality.